Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

[1]  Peter A Pinto,et al.  Management of von Hippel–Lindau-associated kidney cancer , 2005, Nature Clinical Practice Urology.

[2]  S. Libutti,et al.  Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. , 2000, Surgery.

[3]  P L Choyke,et al.  Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. , 1999, The Journal of urology.

[4]  S K Libutti,et al.  Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. , 1998, Surgery.

[5]  S. Libutti,et al.  Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.

[6]  W. Linehan,et al.  Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene , 1998, Human mutation.

[7]  P. Choyke,et al.  von Hippel-Lindau disease: genetic, clinical, and imaging features. , 1995, Radiology.

[8]  D. Hough,et al.  Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. , 1994, AJR. American journal of roentgenology.

[9]  H. Brambs,et al.  Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.

[10]  C. Johnson,et al.  Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. , 1990, AJR. American journal of roentgenology.

[11]  P. Gaines,et al.  The abdominal manifestation of von Hippel-Lindau disease and a radiological screening protocol for an affected family. , 1988, Clinical radiology.